<DOC>
	<DOCNO>NCT02665195</DOCNO>
	<brief_summary>This study do learn change certain gene may link cancer . Some people cancer get disease inherit abnormal ( mutate ) gene . The researcher study want good understand risk link genetic change less well-studied gene . By understand risk , believe doctor able give good advice family mutation gene .</brief_summary>
	<brief_title>Prospective Registry Multiplex Testing ( PROMPT )</brief_title>
	<detailed_description>PROMPT ( Prospective Registry Multiplex Testing ) Internet-based , patient-directed ascertainment study . It partnership Memorial Sloan Kettering , University Pennsylvania , Mayo Clinic , Dana Farber Cancer Institute collaboration Ambry Genetics , GeneDx , Myriad Genetics , Pathway Genomics , Quest Laboratories ( 5 laboratory provide multiplex panel test commercially ) .</detailed_description>
	<criteria>Individual deleterious ( pathogenic ) likely deleterious ( likely pathogenic ) mutation cancer susceptibility gene OR Individual variant uncertain significance ( VUS ) cancer susceptibility gene OR Untested member family know transmit deleterious likely deleterious mutation variant uncertain significance cancer predisposition gene Inability refusal participate consent discussion Subject le 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>